Prof. em. Werner Arber is a pioneer in molecular biological research, investigating the structure and function of DNA and the interaction of genes and proteins. With his discovery of molecular scissors for genes, the…
Precision Microbiota Engineering for Child Health The project “Precision Microbiota Engineering for Child Health”, headed by Prof. Emma Wetter Slack of the ETH Zurich, aims to modify the microbiota of individuals with inborn…
The Swiss Economic Award is the most important young entrepreneur prize in Switzerland. In a multi-stage selection process, T3 Pharma has succeeded from among the 107 applicants and has been awarded the prize in the…
The ERC’s prestigious Starting Grant recognizes innovative research by outstanding early career scientists and enables the recipients to establish their own research program. One of the top researchers to be awarded the…
On 24 August 2020, the University Council approved the appointment of two new professors to the Biozentrum of the University of Basel. Knut Drescher, currently a research group leader at the Max Planck Institute for…
The Sjöberg Prize honors scientist for pioneering research in the field of cancer research. Michael Hall, Biozentrum of the University of Basel, and Prof. David M. Sabatini, are jointly awarded for their discovery of the…
Prof. Richard Neher, who was just recently appointed to the Biozentrum of the University of Basel, and Prof. Trevor Bedford competed successfully with their open access website “ nextstrain.org ” against two other teams in…
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the treatment of diabetes is too low to inhibit cancer growth. The…
Personalized medicine, a drug therapy tailored to the individual patient, is no longer a future vision on the horizon. One of the pioneers of this individualized therapy is Urs A. Meyer, Professor emeritus of Pharmacology.…
T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…
This website uses cookies to collect data from users and improve functionality. By continuing to browse the site you are agreeing to this. Receive more information by reading our privacy policy.
